(Q36355478)

English

Autologous tumor-specific cytotoxic T lymphocytes in the infiltrate of human metastatic melanomas. Activation by interleukin 2 and autologous tumor cells, and involvement of the T cell receptor

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

Autologous tumor-specific cytotoxic T lymphocytes in the infiltrate of human metastatic melanomas. Activation by interleukin 2 and autologous tumor cells, and involvement of the T cell receptor (English)

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

0 references

0 references

Charles M. Balch

3

object named as

C M Balch

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

author name string

K Itoh

1

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

C D Platsoucas

2

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

language of work or name

0 references

publication date

1 October 1988

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

Journal of Experimental Medicine

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

168

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

4

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

1419-1441

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

Inhibition of specific cell-mediated cytotoxicity by monoclonal antibodies to human T cell antigens

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2189080

30 September 2017

Identification of a cell surface protein, p97, in human melanomas and certain other neoplasms

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2189080

30 September 2017

T-cell-mediated cytotoxicity against autologous malignant melanoma: analysis with interleukin 2-dependent T-cell cultures

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2189080

30 September 2017

Clonal analysis of cytotoxic T cell response against human melanoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2189080

30 September 2017

Lymphokine-activated killer cell phenomenon. Lysis of natural killer-resistant fresh solid tumor cells by interleukin 2-activated autologous human peripheral blood lymphocytes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2189080

30 September 2017

Demonstration of a non-Tac peptide that binds interleukin 2: a potential participant in a multichain interleukin 2 receptor complex

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2189080

30 September 2017

Lymphokine-activated killer cells. Analysis of progenitors and effectors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2189080

30 September 2017

Clonal analysis of cytotoxic T lymphocytes (CTL) against autologous melanoma. Classification based on phenotype, specificity and inhibition by monoclonal antibodies to T cell structures

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2189080

30 September 2017

GD3, a prominent ganglioside of human melanoma. Detection and characterisation by mouse monoclonal antibody

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2189080

29 June 2018

Direct demonstration of the clonogenic potential of every human peripheral blood T cell. Clonal analysis of HLA-DR expression and cytolytic activity

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2189080

29 June 2018

Functional analysis of mononuclear cells infiltrating into tumors: lysis of autologous human tumor cells by cultured infiltrating lymphocytes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2189080

29 June 2018

Dissection of the lymphokine-activated killer phenomenon. Relative contribution of peripheral blood natural killer cells and T lymphocytes to cytolysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2189080

29 June 2018

Clonal analysis of cytotoxic T-lymphocyte response to autologous human metastatic melanoma.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2189080

29 June 2018

Identification of specific cytolytic immune responses against autologous tumor in humans bearing malignant melanoma.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2189080

29 June 2018

Characteristics of a monoclonal antibody (WT-31) that recognizes a common epitope on the human T cell receptor for antigen

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2189080

29 June 2018

Interleukin 2 expanded tumor-infiltrating lymphocytes in human renal cell cancer: isolation, characterization, and antitumor activity

1 reference

https://pubmed.ncbi.nlm.nih.gov/3262710

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-term interleukin 2-dependent growth and cytotoxic activity of tumor-infiltrating lymphocytes from human squamous cell carcinomas of the head and neck

1 reference

https://pubmed.ncbi.nlm.nih.gov/3262710

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The in vivo distribution of autologous human and murine lymphoid cells grown in T cell growth factor (TCGF): implications for the adoptive immunotherapy of tumors

1 reference

https://pubmed.ncbi.nlm.nih.gov/3262710

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cloned human cytotoxic T lymphocyte (CTL) lines reactive with autologous melanoma cells. I. In vitro generation, isolation, and analysis to phenotype and specificity

1 reference

https://pubmed.ncbi.nlm.nih.gov/3262710

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Human T cell antigens involved in cytotoxicity against allogeneic or autologous chemically modified targets. Association of the Leu 2a/T8 antigen with effector-target cell binding and of the T3/Leu 4 antigen with triggering

1 reference

https://pubmed.ncbi.nlm.nih.gov/3262710

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Leu-11+ lymphocytes with natural killer (NK) activity are precursors of recombinant interleukin 2 (rIL 2)-induced activated killer (AK) cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/3262710

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Lysis of anti-T3-bearing murine hybridoma cells by human allospecific cytotoxic T cell clones and inhibition of that lysis by anti-T3 and anti-LFA-1 antibodies

1 reference

https://pubmed.ncbi.nlm.nih.gov/3262710

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Role of interleukin 2 and a serum suppressive factor on the induction of activated killer cells cytotoxic for autologous human melanoma cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/3262710

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Lysis of human solid tumor cells by lymphokine-activated natural killer cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/3262710

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Destruction of autologous human lymphocytes by interleukin 2-activated cytotoxic cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/3262710

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Human lymphokine-activated killer (LAK) cells: identification of two types of effector cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/3262710

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phenotypic and functional characterization of recombinant interleukin 2 (rIL 2)-induced activated killer cells: analysis at the population and clonal levels

1 reference

https://pubmed.ncbi.nlm.nih.gov/3262710

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Natural killer cells in the host response to melanoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/3262710

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Production of stable cytolytic T-cell clones directed against autologous human melanoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/3262710

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Interleukin 2-activated human lymphocytes exhibit enhanced adhesion to normal vascular endothelial cells and cause their lysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/3262710

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

In vivo distribution of recombinant interleukin-2-activated autologous lymphocytes administered by intra-arterial infusion in patients with renal cell carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/3262710

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A progress report on the treatment of 157 patients with advanced cancer using lymphokine-activated killer cells and interleukin-2 or high-dose interleukin-2 alone

1 reference

https://pubmed.ncbi.nlm.nih.gov/3262710

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Constant-infusion recombinant interleukin-2 in adoptive immunotherapy of advanced cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/3262710

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-term growth of lymphokine-activated killer (LAK) cells: role of anti-CD3, beta-IL 1, interferon-gamma and -beta

1 reference

https://pubmed.ncbi.nlm.nih.gov/3262710

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Lysis of fresh solid tumor targets in the presence of Con A is mediated primarily by Leu 7+ peripheral blood T lymphocytes: blocking by the anti-CD3 monoclonal antibody and comparison with recombinant interleukin 2-induced lysis by natural killer ce

1 reference

https://pubmed.ncbi.nlm.nih.gov/3262710

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1084/JEM.168.4.1419

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36355478&oldid=1627601680"